Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

Kait Handler's debilitating battle with food started as a child. So when she noticed her daughter developing the same diet ...